These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 18598882)

  • 1. [AMBIZYGO: phase II study of high dose liposomal amphotericin B (AmBisome) [10 mg/kg/j] efficacy against zygomycosis].
    Lanternier F; Lortholary O
    Med Mal Infect; 2008 Jun; 38 Suppl 2():S90-1. PubMed ID: 18598882
    [No Abstract]   [Full Text] [Related]  

  • 2. AmBisome today: expanding the perspectives on liposomal amphotericin B.
    Richardson M
    Acta Biomed; 2006; 77 Suppl 2():3-4. PubMed ID: 16918058
    [No Abstract]   [Full Text] [Related]  

  • 3. Use of high-dose liposomal amphotericin B: efficacy and tolerance.
    Garbino J; Adam A
    Acta Biomed; 2006; 77 Suppl 4():19-22. PubMed ID: 17370566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cure of disseminated zygomycosis with cerebral involvement using high dose liposomal amphotericin B and surgery.
    Revankar SG; Hasan MS; Smith JW
    Med Mycol; 2007 Mar; 45(2):183-5. PubMed ID: 17365655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rhino-orbital zygomycosis secondary to Rhizopus oryzae in a renal transplant recipient successfully treated with liposomal amphotericin B.
    Yassin MA; Taj-Aldeen SJ; Khan FY; Errayes M; Aref E
    Chang Gung Med J; 2008; 31(4):407-11. PubMed ID: 18935800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid formulations of amphotericin B as first-line treatment of zygomycosis.
    Petrikkos GL
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():87-92. PubMed ID: 19754765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.
    Chamilos G; Lewis RE; Kontoyiannis DP
    Clin Infect Dis; 2008 Aug; 47(4):503-9. PubMed ID: 18611163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Favourable outcome of pulmonary zygomycosis in haematological malignancy.
    Opeskin K; Sheorey H; Wright G; Nandurkar H
    Pathology; 2006 Jun; 38(3):271-3. PubMed ID: 16753758
    [No Abstract]   [Full Text] [Related]  

  • 9. Zygomycosis and diabetes mellitus.
    Lanternier F; Lortholary O
    Clin Microbiol Infect; 2009 Oct; 15 Suppl 5():21-5. PubMed ID: 19754752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of cutaneous zygomycosis.
    Visser DH; van den Berg YL; van Furth AM; Oomen MW; Schouten-van Meeteren AY; Pajkrt D; van den Bos C; van Well GT
    Pediatr Infect Dis J; 2007 Dec; 26(12):1165-6. PubMed ID: 18043463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Editorial commentary: what is the role of combination therapy in management of zygomycosis?
    Walsh TJ; Kontoyiannis DP
    Clin Infect Dis; 2008 Aug; 47(3):372-4. PubMed ID: 18558877
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of liposomal amphotericin B combined with gamma interferon or granulocyte-macrophage colony-stimulating factor for treatment of systemic zygomycosis in mice.
    Rodríguez MM; Calvo E; Mariné M; Pastor FJ; Fernandez-Ballart J; Guarro J
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3569-71. PubMed ID: 19451289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zygomycosis of the penis due to Rhizopus oryzae successfully treated with surgical debridement and a combination of high-dose liposomal and topical amphotericin B.
    Cohen-Ludmann C; Kerob D; Feuilhade M; Chaine B; Guermazi A; Janier M; Levy A; Verola O; Morel P; Lebbe C; Lacroix C
    Arch Dermatol; 2006 Dec; 142(12):1657-8. PubMed ID: 17179006
    [No Abstract]   [Full Text] [Related]  

  • 14. Zygomycosis--a case report and overview of the disease in India.
    Diwakar A; Dewan RK; Chowdhary A; Randhawa HS; Khanna G; Gaur SN
    Mycoses; 2007 Jul; 50(4):247-54. PubMed ID: 17576314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syncephalastrum species producing mycetoma-like lesions.
    Amatya R; Khanal B; Rijal A
    Indian J Dermatol Venereol Leprol; 2010; 76(3):284-6. PubMed ID: 20445304
    [No Abstract]   [Full Text] [Related]  

  • 16. Micafungin versus liposomal amphotericin B for pediatric patients with invasive candidiasis: substudy of a randomized double-blind trial.
    Queiroz-Telles F; Berezin E; Leverger G; Freire A; van der Vyver A; Chotpitayasunondh T; Konja J; Diekmann-Berndt H; Koblinger S; Groll AH; Arrieta A;
    Pediatr Infect Dis J; 2008 Sep; 27(9):820-6. PubMed ID: 18679151
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased virulence of Zygomycetes organisms following exposure to voriconazole: a study involving fly and murine models of zygomycosis.
    Lamaris GA; Ben-Ami R; Lewis RE; Chamilos G; Samonis G; Kontoyiannis DP
    J Infect Dis; 2009 May; 199(9):1399-406. PubMed ID: 19358672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fusarium keratitis and endophthalmitis treated by intravenous ambisome].
    Avisar I; Weinberger D; Kremer I
    Harefuah; 2009 Jan; 148(1):28-9, 88. PubMed ID: 19320385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous zygomycosis at catheter insertion site in AML-M4Eo.
    Mueller BU; Pabst T
    Ann Hematol; 2006 Mar; 85(3):194-5. PubMed ID: 16391910
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and efficacy of high-dose infusions of a preformed amphotericin B fat emulsion for treatment of Indian visceral leishmaniasis.
    Sundar S; Singh A; Agarwal D; Rai M; Agrawal N; Chakravarty J
    Am J Trop Med Hyg; 2009 May; 80(5):700-3. PubMed ID: 19407109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.